Literature DB >> 954842

Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs.

B H Westerink, J Korf.   

Abstract

A concurrent semi-automatic fluorometric assay technique for 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), is described. The method is based on a rapid manually performed isolation of DOPAC and HVA on small columns of Sephadex G-10 followed by an automated fluorometric detection with a continuous flow system. DOPAC and HVA were measured in the corpus striatum, nucleus accumbens and olfactory tubercle of the rat, under normal conditions and after treatment with amphetamine, apomorphine, clozapine, haloperidol, morphine, oxotremorine, pargyline, probenecid, sulpiride and thioridazine. Clozapine, morphine, sulpiride and oxotremorine induced the most pronounced rise of DA metabolites in the nucleus accumbens. Probenecid produced a DOPAC accumulation in the nucleus accumbens. Striking differences were observed between the DOPAC/HVA ratios in the different structures of control animals. The concurrent assay enables a rapid screening of the action of drugs in regional DA metabolism.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 954842     DOI: 10.1016/0014-2999(76)90331-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  31 in total

1.  Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: evidence for two different mechanisms of action.

Authors:  T Ljungberg; U Ungerstedt
Journal:  Psychopharmacology (Berl)       Date:  1978-04-11       Impact factor: 4.530

2.  Different effects of opiate withdrawal on dopamine turnover, uptake, and release in the striatum and nucleus accumbens.

Authors:  S Ghosh; A H Patel; M Cousins; K Grasing
Journal:  Neurochem Res       Date:  1998-06       Impact factor: 3.996

3.  BRL 20596, a novel anilide with central dopamine antagonist activity.

Authors:  W Campbell; M S Clark; P J Mitchell; P L Needham; J M Semple
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Motor effects following application of putative excitatory amino acid antagonists to the region of the mesencephalic dopamine cell bodies in the rat.

Authors:  D Dawbarn; C J Pycock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-12       Impact factor: 3.000

5.  Modulation of dopaminergic transmission by alpha-noradrenergic agonists and antagonists: evidence for antidopaminergic properties of some alpha antagonists.

Authors:  P C Waldmeier; R Ortmann; S Bischoff
Journal:  Experientia       Date:  1982-10-15

6.  Induction of dopaminergic supersensitivity after a single dose of the neuroleptic isofloxythepin.

Authors:  M Valchár; J Metysová; J Chlebounová; A Dlabac
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

7.  Effect of morphine on dopaminergic neurons in the rat basal forebrain and striatum.

Authors:  P Moleman; J Bruinvels
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

8.  A radioenzymatic method to measure picogram amounts of dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) in small samples of brain tissue.

Authors:  A Argiolas; F Fadda
Journal:  Experientia       Date:  1978-06-15

Review 9.  Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia.

Authors:  A Fitton; R C Heel
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

10.  Morphine-induced hyperactivity in rats--a rebound effect?

Authors:  B Magnus-Ellenbroek; U Havemann-Reinecke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.